Bar Stéphane, Fischer Marc-Olivier
Anesthesiology and Critical Care Department, Amiens University Hospital, Amiens, France.
Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesthésie Réanimation, Caen, France.
J Thorac Dis. 2019 Jul;11(Suppl 11):S1568-S1573. doi: 10.21037/jtd.2019.01.80.
Tissue hypoperfusion is a major cause of morbidity and mortality in critically ill patients but cannot always be detected by measuring standard whole-body hemodynamic and oxygen-related parameters (e.g., blood pressure, cardiac output, and central venous oxygen saturation). Preclinical and clinical studies have demonstrated that low-flow states are consistently associated with large increases in venous and tissue PCO. Monitoring regional PCO with gastric tonometry (PgCO) is known to have independent prognostic value for predicting postoperative complications and mortality. The PgCO gap might also be of value as a treatment target (endpoint) in critically ill patients. However, this tool has several limitations and has not yet been developed commercially, thus restricting its use. Regional capnography with sublingual and transcutaneous sensors might be an alternative noninvasive option for evaluating the adequacy of tissue perfusion in critically ill patients. However, further studies are needed to determine whether or not this monitoring technique is of value-particularly as an endpoint for guiding resuscitation. Bladder PCO, has only been evaluated in animal studies, and so remains to be validated in patients.
组织灌注不足是危重症患者发病和死亡的主要原因,但通过测量标准的全身血流动力学和氧相关参数(如血压、心输出量和中心静脉血氧饱和度)并不总能检测到。临床前和临床研究表明,低流量状态始终与静脉和组织PCO大幅升高相关。通过胃张力计监测区域PCO(PgCO)已知对预测术后并发症和死亡率具有独立的预后价值。PgCO差值作为危重症患者的治疗靶点(终点)可能也具有价值。然而,该工具存在若干局限性且尚未商业化开发,因此限制了其应用。使用舌下和经皮传感器进行区域二氧化碳监测可能是评估危重症患者组织灌注充足性的另一种非侵入性选择。然而,需要进一步研究以确定这种监测技术是否有价值,特别是作为指导复苏的终点。膀胱PCO仅在动物研究中进行了评估,因此仍有待在患者中进行验证。